증권사 리포트&코멘트09.26 10:32
Novo Nordisk, Nanexa와 최대 €1.165bn 장기지속형 계약
#타이드
prnewswire.com
Nanexa and Novo enter into EUR 1.165 billion global license and collaboration agreement for long-acting injectables
The agreement grants Novo a global exclusive license to Nanexa's proprietary PharmaShell® atomic layer deposition (ALD) drug delivery technology platform for...
pharmbiohana ↗